1-(2-羟基乙基)-2,6-二氧代-3H-嘧啶-4-羧酸 | 31822-29-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 中文名称: 1-(2-羟基乙基)-2,6-二氧代-3H-嘧啶-4-羧酸
• 英文名称: 3-(β-Hydroxyethyl)orotsaeure
• 英文别名: 1-(2-hydroxy-ethyl)-2,6-dioxo-1,2,3,6-tetrahydro-pyrimidine-4-carboxylic acid；1,2,3,6-Tetrahydro-1-(2-hydroxyethyl)-2,6-dioxopyrimidine-4-carboxylic acid；3-(2-hydroxyethyl)-2,4-dioxo-1H-pyrimidine-6-carboxylic acid
• CAS: 31822-29-4
• 化学式: C₇H₈N₂O₅
• 分子量: 200.151
• InChiKey: JUYJMQNDFCMXIL-UHFFFAOYSA-N

物化性质

• 密度：
  1.599±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  -1.7
• 重原子数：
  14
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  107
• 氢给体数：
  3
• 氢受体数：
  5

安全信息

• 海关编码：
  2933599090

文献信息

• COMPOUNDS THAT INHIBIT HUMAN DNA LIGASES AND METHODS OF TREATING CANCER
  申请人：TOMKINSON Alan E.

  公开号：US20100099683A1

  公开（公告）日：2010-04-22

  Methods for treating cancer using compounds that inhibit human DNA ligases. Methods for using compounds that inhibit human DNA ligases to provide insights into the reaction mechanisms of human DNA ligases, for example to identify the human DNA ligase involved in different DNA repair pathways. Screening methods for compounds that inhibit human DNA ligases.
• Compounds that inhibit human DNA ligases and methods of treating cancer
  申请人：University of Maryland, Baltimore

  公开号：US20140113891A1

  公开（公告）日：2014-04-24

  Methods for treating cancer using compounds that inhibit human DNA ligases. Methods for using compounds that inhibit human DNA ligases to provide insights into the reaction mechanisms of human DNA ligases, for example to identify the human DNA ligase involved in different DNA repair pathways. Screening methods for compounds that inhibit human DNA ligases.
• US8445537B2
  申请人：——

  公开号：US8445537B2

  公开（公告）日：2013-05-21
• US9073896B2
  申请人：——

  公开号：US9073896B2

  公开（公告）日：2015-07-07
• US9757375B2
  申请人：——

  公开号：US9757375B2

  公开（公告）日：2017-09-12